These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24284154)

  • 1. Patterns of use and outcomes for radiation therapy in the Quality Initiative in Rectal Cancer (QIRC) trial.
    Francescutti V; Coates A; Thabane L; Goldsmith CH; Levine MN; Simunovic M
    Can J Surg; 2013 Dec; 56(6):E148-53. PubMed ID: 24284154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Quality Initiative in Rectal Cancer (QIRC) trial: study protocol of a cluster randomized controlled trial in surgery.
    Simunovic M; Goldsmith C; Thabane L; McLeod R; Denardi F; Whelan TJ; Levine MN
    BMC Surg; 2008 Feb; 8():4. PubMed ID: 18279521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of an innovation in surgery: observations from the cluster-randomized Quality Initiative in Rectal Cancer trial.
    Simunovic M; Coates A; Smith A; Thabane L; Goldsmith CH; Levine MN
    Can J Surg; 2013 Dec; 56(6):415-21. PubMed ID: 24284150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the status of the mesorectal fascia in the selection of patients with rectal cancer for preoperative radiation therapy: a retrospective cohort study.
    Simunovic M; Grubac V; Zbuk K; Wong R; Coates A
    Can J Surg; 2018 Oct; 61(5):332-338. PubMed ID: 30247008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer.
    Ceelen WP; Van Nieuwenhove Y; Fierens K
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006041. PubMed ID: 19160264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial.
    Erlandsson J; Holm T; Pettersson D; Berglund Å; Cedermark B; Radu C; Johansson H; Machado M; Hjern F; Hallböök O; Syk I; Glimelius B; Martling A
    Lancet Oncol; 2017 Mar; 18(3):336-346. PubMed ID: 28190762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome.
    Myerson RJ; Michalski JM; King ML; Birnbaum E; Fleshman J; Fry R; Kodner I; Lacey D; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):41-50. PubMed ID: 7721638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
    Cafiero F; Gipponi M; Lionetto R;
    J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of patients receiving radiation for carcinoma of the rectum. Results of the 1988-1989 patterns of care study.
    Coia LR; Gunderson LL; Haller D; Hoffman J; Mohiuddin M; Tepper JE; Berkey B; Owen JB; Hanks GE
    Cancer; 1999 Nov; 86(10):1952-8. PubMed ID: 10570418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service.
    Enker WE; Merchant N; Cohen AM; Lanouette NM; Swallow C; Guillem J; Paty P; Minsky B; Weyrauch K; Quan SH
    Ann Surg; 1999 Oct; 230(4):544-52; discussion 552-4. PubMed ID: 10522724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal cancer: changing patterns of referral for radiation therapy 1982-1997.
    Stevens G; Firth I; Solomon M; Saw R; Glenn D; Eyers A; West R
    Aust N Z J Surg; 2000 Aug; 70(8):553-9. PubMed ID: 10945546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.
    Sebag-Montefiore D; Stephens RJ; Steele R; Monson J; Grieve R; Khanna S; Quirke P; Couture J; de Metz C; Myint AS; Bessell E; Griffiths G; Thompson LC; Parmar M
    Lancet; 2009 Mar; 373(9666):811-20. PubMed ID: 19269519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monthly tegafur-uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study.
    Kuo YH; Lai CH; Huang CY; Chen CJ; Huang YC; Huang WS; Chin CC
    BMC Cancer; 2019 Aug; 19(1):815. PubMed ID: 31419963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple primary tumors following stage II and III rectal cancer in patients receiving radiotherapy, 1998-2010.
    Smith-Gagen J; Goodwin GA; Tay J
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):949-55. PubMed ID: 24663823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance, epidemiology, and end results-based analysis of the impact of preoperative or postoperative radiotherapy on survival outcomes for T3N0 rectal cancer.
    Peng LC; Milsom J; Garrett K; Nandakumar G; Coplowitz S; Parashar B; Nori D; Clifford Chao KS; Wernicke AG
    Cancer Epidemiol; 2014 Feb; 38(1):73-8. PubMed ID: 24491755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant Radiotherapy Versus Surgery Alone for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors: A Prospective Multicenter Stratified Randomized Trial.
    Deng X; Liu P; Jiang D; Wei M; Wang X; Yang X; Zhang Y; Wu B; Liu Y; Qiu M; Zhuang H; Zhou Z; Li Y; Xu F; Wang Z
    Ann Surg; 2020 Dec; 272(6):1060-1069. PubMed ID: 31599809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant external beam and intraoperative radiation therapy in rectal cancer.
    Minsky BD; Cohen AM
    Cancer Invest; 1989; 7(5):493-507. PubMed ID: 2695231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial.
    Bujko K; Michalski W; Kepka L; Nowacki MP; Nasierowska-Guttmejer A; Tokar P; Dymecki D; Pawlak M; Lesniak T; Richter P; Wojnar A; Chmielik E;
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):369-77. PubMed ID: 17118570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.